Publication
Combinatorial delivery of Crizotinib–Palbociclib–Sildenafil using TPGS-PLA micelles for improved cancer treatment
dc.contributor.author | Diogo, Duarte Miguel de Melo | |
dc.contributor.author | Gaspar, Vítor Manuel Abreu | |
dc.contributor.author | Costa, Elisabete C. | |
dc.contributor.author | Moreira, André | |
dc.contributor.author | Oppolzer, David | |
dc.contributor.author | Gallardo, Eugenia | |
dc.contributor.author | Correia, Ilídio Joaquim Sobreira | |
dc.date.accessioned | 2018-03-20T14:32:56Z | |
dc.date.available | 2018-03-20T14:32:56Z | |
dc.date.issued | 2014-10-13 | |
dc.description.abstract | The co-delivery of multiple chemotherapeutics by micellar delivery systems is a valuable approach to improve cancer treatment since various disease hallmarks can be targeted simultaneously. However, the delivery of multiple drugs requires a nanocarrier structure that can encapsulate various bioactive molecules. In this study, we evaluate the simultaneous encapsulation of a novel triple drug combination in D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) (TPGS-PLA) amphiphilic micelles for cancer therapy. The drug mixture involves two anti-tumoral drugs, Crizotinib and Palbociclib combined with Sildenafil, a compound that is capable of increasing drug accumulation in the intracellular compartment. Such combination aims to achieve an enhanced cytotoxic effect in cancer cells. Our results demonstrated that TPGS-PLA copolymers self-assembled into stable nanosized micelles (158.3 nm) capable of co-encapsulating the three drugs with high loading efficiency. Triple drug loaded TPGS-PLA micelles were internalized in A549 non-small lung cancer cells and exhibited an improved cytotoxic effect in comparison with single (Crizotinib) or dual (Crizotinib–Palbociclib) drug loaded micelles, indicating the therapeutic potential of the triple co-delivery strategy. These findings demonstrate that TPGS-PLA micelles are suitable carriers for multiple drug delivery and also that this particular drug combination may have potential to improve cancer treatment. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | De Melo-Diogo, D., Gaspar, V.M., Costa, E.C., Moreira, A.F., Markl, D., Gallardo, E. e Correia, I.J. (2014) “Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment”, European Journal of Pharmaceutics and Biopharmaceutics, Vol. 88 (3), pp. 718-729 | pt_PT |
dc.identifier.doi | 10.1016/j.ejpb.2014.09.013 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.6/4657 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.relation | Strategic Project - UI 709 - 2011-2012 | |
dc.relation | 2014 - Strategic Project | |
dc.relation | BIOSYNTHESIS AND PURIFICATION OF MINICIRCLE DNA FOR APPLICATION IN DIABETES CELL-SPECIFIC GENE THERAPY | |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0939641114002847 | pt_PT |
dc.subject | Cancer | pt_PT |
dc.subject | Co-delivery | pt_PT |
dc.subject | Micellar carriers | pt_PT |
dc.subject | Multidrug therapy | pt_PT |
dc.subject | Non-small cell lung cancer | pt_PT |
dc.subject | TPGS-PLA copolymer | pt_PT |
dc.title | Combinatorial delivery of Crizotinib–Palbociclib–Sildenafil using TPGS-PLA micelles for improved cancer treatment | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Strategic Project - UI 709 - 2011-2012 | |
oaire.awardTitle | 2014 - Strategic Project | |
oaire.awardTitle | BIOSYNTHESIS AND PURIFICATION OF MINICIRCLE DNA FOR APPLICATION IN DIABETES CELL-SPECIFIC GENE THERAPY | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6820 - DCRRNI ID/PEst-C%2FSAU%2FUI0709%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FSAU%2FUI0709%2F2014/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F80402%2F2011/PT | |
oaire.citation.endPage | 729 | pt_PT |
oaire.citation.startPage | 718 | pt_PT |
oaire.citation.title | European Journal of Pharmaceutics and Biopharmaceutics | pt_PT |
oaire.citation.volume | 88 | pt_PT |
oaire.fundingStream | 6820 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | FARH | |
person.familyName | Miguel de Melo Diogo | |
person.familyName | Gaspar | |
person.familyName | da Rocha Costa | |
person.familyName | Moreira | |
person.familyName | Oppolzer | |
person.familyName | Gallardo | |
person.familyName | Joaquim Sobreira Correia | |
person.givenName | Duarte | |
person.givenName | Vítor | |
person.givenName | Elisabete Cristina | |
person.givenName | André Ferreira | |
person.givenName | David | |
person.givenName | Eugenia | |
person.givenName | Ilídio | |
person.identifier | C2z5x04AAAAJ | |
person.identifier | 1161643 | |
person.identifier | 908303 | |
person.identifier | UMbJ1KMAAAAJ | |
person.identifier.ciencia-id | 9C10-9BD8-634E | |
person.identifier.ciencia-id | 6F16-3640-73E3 | |
person.identifier.ciencia-id | B314-4CF0-6633 | |
person.identifier.ciencia-id | 4C1E-012B-83CE | |
person.identifier.ciencia-id | F617-5CA5-EF61 | |
person.identifier.ciencia-id | F610-7373-DC81 | |
person.identifier.orcid | 0000-0001-9984-3603 | |
person.identifier.orcid | 0000-0002-0372-2493 | |
person.identifier.orcid | 0000-0002-0490-0095 | |
person.identifier.orcid | 0000-0002-0604-2506 | |
person.identifier.orcid | 0000-0002-8888-4976 | |
person.identifier.orcid | 0000-0002-1802-8998 | |
person.identifier.orcid | 0000-0003-1613-9675 | |
person.identifier.rid | B-1602-2017 | |
person.identifier.rid | M-7410-2017 | |
person.identifier.scopus-author-id | 56266511300 | |
person.identifier.scopus-author-id | 36968590900 | |
person.identifier.scopus-author-id | 55805850100 | |
person.identifier.scopus-author-id | 56401521300 | |
person.identifier.scopus-author-id | 55623902200 | |
person.identifier.scopus-author-id | 24721485300 | |
person.identifier.scopus-author-id | 7003557499 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.embargofct | Copyright cedido à editora no momento da publicação | pt_PT |
rcaap.rights | closedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 8525f1be-ff8f-4e46-b158-e59928e8a3e5 | |
relation.isAuthorOfPublication | 3eeac15e-ebf4-4dc2-aeb8-698087d6d2fc | |
relation.isAuthorOfPublication | bfc28f1b-bd1b-4564-97e3-ae6a0c3b6c0c | |
relation.isAuthorOfPublication | e20bf724-86f1-4fc8-800d-39ff19b624b1 | |
relation.isAuthorOfPublication | 6fb520dc-95bc-4d6a-8f9e-a290865468f7 | |
relation.isAuthorOfPublication | 9763ebec-c3f5-4cc9-b5df-8d3c045ed4ec | |
relation.isAuthorOfPublication | f2c3e779-34a2-4309-950a-80687664c6ad | |
relation.isAuthorOfPublication.latestForDiscovery | 6fb520dc-95bc-4d6a-8f9e-a290865468f7 | |
relation.isProjectOfPublication | 46f27240-144c-4bb9-8ca6-1fe82721b1c2 | |
relation.isProjectOfPublication | 73e4c414-017f-4f3f-a7b1-47e2b8e1246c | |
relation.isProjectOfPublication | 3fb6412e-24d9-4127-ac65-a0e6dbaaf79d | |
relation.isProjectOfPublication.latestForDiscovery | 73e4c414-017f-4f3f-a7b1-47e2b8e1246c |